The global preventive vaccines market growing at a CAGR of 10.7%, claims Roots Analysis

 

Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2020-2030”.

 

The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:

§  A detailed assessment of the current market landscape, featuring clinical-stage preventive vaccines.

§  A competitiveness analysis of preventive vaccine developers, featuring insightful pictorial summaries and representations.

§  Elaborate profiles of the key preventive vaccine developers (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific.

§  An in-depth analysis of the completed, ongoing and planned trials of various preventive vaccines.

§  An overview of the ongoing vaccine development initiatives for complex conditions, such as COVID-19, Ebola virus disease, HIV/AIDS, malaria and zika virus infection.

§  An analysis of the investments made in this domain, during the period between 2015 and 2020 (till March).

§  A case study on contract manufacturing landscape for vaccines, featuring the CMOs engaged in this domain.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Route of Administration

§  Intramuscular

§  Subcutaneous

§  Oral

§  Intravenous

§  Others

 

§  Type of Vaccine

§  Pneumococcal Conjugate Vaccine

§  Human Papilloma Virus Vaccine

§  Rotavirus Vaccine

§  Influenza Vaccine

§  MMR Vaccine

§  Tetanus and Diphtheria Booster Vaccine

§  Varicella Vaccine

§  DTaP-Hib-IPV Vaccine

§  DTaP-HepB-Hib-IPV Vaccine

§  Others

 

§  Type of Vaccine API

§  Live, Attenuated Vaccine

§  Inactivated Vaccine

§  Conjugate Vaccine

§  Subunit Vaccine

§  Toxoid Vaccine

§  Others

§  Target Patient Population

§  Pediatric Patients

§  Adults

 

§  Key Players

§  GlaxoSmithKline

§  Merck

§  Sanofi Pasteur

§  Pfizer

§  Emergent BioSolutions

§  CSL

§  Others

 

§  Key Geographical Regions 

§  North America

§  Europe

§  Asia Pacific

§  Rest of the World 

 

Key companies covered in the report

§  Bio Farma

§  Emergent BioSolutions

§  GC Pharma

§  GlaxoSmithKline

§  Janssen

§  Merck

§  Novavax

§  Pfizer

§  Sanofi Pasteur

§  Valneva

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

 

Other Recent Offerings

§  Novel coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development

§  Novel Vaccine Delivery Devices Market, 2019-2030 [COVID-19 SERIES]

§  Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030 [COVID-19 SERIES]

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Details

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

 

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora: https://rootsanalysisinsights.quora.com/

Comments

Post a Comment

Popular posts from this blog

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

    Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals   Roots Analysis is pleased to announce the publication of its recent study, titled “ Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 ” report to its list of offerings.   The report provides a detailed study on the current market landscape and future potential of biologics designed for subcutaneous administration. In addition, the study provides an in-depth analysis of the formulation technologies and drug delivery systems (focusing on large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug reconstitution systems, prefilled syringes and implants) that enable subcutaneous delivery of the biologic drugs. Amongst other elements, the r...
Read more

PRE-INSTALLED SINGLE-USE SENSORS FOR BIOPROCESSING-CASE STUDY

    During our research, we identified 31 pre-installed single-use sensors developed by various companies for bioprocessing. The current market landscape is predominantly characterized by the presence of large (38%) and small (37%) players. Notable examples of large players in this domain include ( in alphabetical order ) Cytiva Life Sciences (US), Hamilton (US) and Pall (US).   To Request Sample Pages -: https://www.rootsanalysis.com/reports/single-use-sensors-for-bioprocessing.html       Majority of the pre-installed single-use sensor systems are designed for both, research and biomanufacturing purposes. This is followed by those designed for only research purposes. Notable examples of products which are developed for both research and biomanufacturing applications, include ( arranged alphabetically ) ÄKTA ready XL sensor technology (Cytiva Life Sciences), Allegro™ MVP Single-Use System (Pall Corporation) and FUTURA pico (Aber Instruments)...
Read more